Eli Lilly wins FDA emergency clearance for COVID-19 antibody drug

The Food and Drug Administration cleared the company’s synthetic antibody treatment, but short supplies and logistical challenges could limit its initial impact.

Show CommentsClose Comments

Leave a comment

%d bloggers like this: